Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2023, Vol. 28 ›› Issue (8): 866-875.doi: 10.12092/j.issn.1009-2501.2023.08.003
Previous Articles Next Articles
FU Xiaoyu, KONG Deguang, LI Juanjuan
Received:
Revised:
Online:
Published:
Abstract:
Key words: triple positive breast cancer, crosstalk, treatment strategy, biomarkers
CLC Number:
R737.9
FU Xiaoyu, KONG Deguang, LI Juanjuan. Treatment progress of triple positive breast cancer[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 866-875.
0 / / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: https://manu41.magtech.com.cn/Jweb_clyl/EN/10.12092/j.issn.1009-2501.2023.08.003
https://manu41.magtech.com.cn/Jweb_clyl/EN/Y2023/V28/I8/866